Aug 2 (Reuters) - Medical device company CryoCor Inc. said the U.S. Food and Drug Administration has granted pre-market approval for its device for the treatment of right atrial flutter, or abnormal ...

WASHINGTON, June 27 (Reuters) - A U.S. advisory panel backed an experimental CryoCor Inc. device to treat a type of abnormal heart rhythm, a Food and Drug Administration spokeswoman said on Wednesday.

Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), together with Amsterdam University Medical Centre (Amsterdam ...

SAN FRANCISCO (MarketWatch) -- CryoCor Inc. said after the closing bell on Thursday it has received notification from the Food and Drug Administration that its pre-market approval application for the ...